HomeORGANIZATION
ORGANIZATION

Impact of Drug Price Revisions on Company Management Unclear: JMA Think Tank
(Aug.22.2017)

The kind of impact biennial price revisions have on company management is “not very clear,” and their earnings from ethical drug businesses in Japan should thus be reported separately from revenues elsewhere, a think tank arm of the Japan Medical Association (JMA) says ...
(LOG IN FOR FULL STORY)

News Calendar